Ascendis Pharma A/S EV/EBIT
What is the EV/EBIT of Ascendis Pharma A/S?
The EV/EBIT of Ascendis Pharma A/S is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Ascendis Pharma A/S
What does Ascendis Pharma A/S do?
ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
Companies with ev/ebit similar to Ascendis Pharma A/S
- Surface Transforms Plc has EV/EBIT of N/A
- Boqii Ltd has EV/EBIT of N/A
- Sunrun has EV/EBIT of N/A
- Mind Medicine (MindMed) has EV/EBIT of N/A
- Coveo Solutions has EV/EBIT of N/A
- Innovative Designs has EV/EBIT of N/A
- Ascendis Pharma A/S has EV/EBIT of N/A
- Biomerica has EV/EBIT of N/A
- Crescent NV has EV/EBIT of N/A
- Ivrnet has EV/EBIT of N/A
- Orion Office REIT has EV/EBIT of N/A
- Ansal Properties & Infrastructure has EV/EBIT of N/A
- Nanophase Technologies has EV/EBIT of N/A